pulmonary nodule resection, pulmonary tumor resection, and mediastinal tumor resection
Conditions
Interventions
Using sufentanil as the postoperative analgesic:None
Using the combination of hydromorphone and nalbuphine as postoperative analgesics:None
Sponsors
The Affiliated Hospital of Inner Mongolia Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients aged > 18 years old, with ASA physical status grade ?–? and body mass index (BMI) ranging from 18 to 30 kg/m². 2. Surgical types include thoracotomy or video-assisted thoracoscopic surgery (VATS) such as lobectomy, segmentectomy, mediastinal tumor resection, radical esophagectomy, etc. The duration of surgery is = 2 hours. 3. Patients and their family members have understood the study protocol and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with hypersensitivity to the drugs involved in this study will be excluded. 2. Patients with dysfunction of major organs such as cardiopulmonary, hepatic and renal functions will be excluded. 3. Patients with neurological diseases, mental disorders, those who are pregnant or lactating, and those who have participated in other clinical trials recently (within 1 month) will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale;IL-1ß;IL-6;IL-17;TGF-ß1; | — |
Countries
China
Contacts
Public ContactXin Wang
The Affiliated Hospital of Inner Mongolia Medical University
Outcome results
None listed